FGAM
PBYI icon

Financial Gravity Asset Management’s Puma Biotechnology PBYI Stock Holding History

Financial Gravity Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$9K Hold
1
– – 0.01% 1208
2019
Q3 		$0 Hold
1
– – ﹤0.01% 1457
2019
Q2 		$0 Hold
1
– – ﹤0.01% 1552
2019
Q1 		$0 Buy
+1
New +$31 ﹤0.01% 1483
2018
Q3 		$0 Hold
1
– – ﹤0.01% 1560
2018
Q2 		$0 Hold
1
– – ﹤0.01% 1564
2018
Q1 		$0 Buy
+1
New +$75 ﹤0.01% 1476

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Financial Gravity Asset Management's PBYI Position: Q4 2019 in Review

Financial Gravity Asset Management held its Puma Biotechnology (PBYI) position steady in Q4 2019 at 1 share worth $9K. The position accounts for 0.01% of the portfolio, ranked #1208.

Financial Gravity Asset Management first reported a position in PBYI in Q1 2018 and has held it in 7 quarters since. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2019.

  • Financial Gravity Asset Management held 1 share of Puma Biotechnology worth $9K as of Q4 2019.
  • Financial Gravity Asset Management left its Puma Biotechnology share count unchanged in Q4 2019.
  • Puma Biotechnology made up 0.01% of Financial Gravity Asset Management's portfolio in Q4 2019, its #1208 holding.
  • Financial Gravity Asset Management first reported a position in Puma Biotechnology in Q1 2018 and has held it in 7 quarters since.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.